APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Pathology Analysis System

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI Pathology Analysis System Market Analysis and Forecast 2026-2032

2 May 2026198 pages

Choose your research edition.

Industry ResearchAI Pathology Analysis System Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Pathology Analysis System Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal AI Pathology Analysis System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Pathology Analysis System Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Pathology Analysis System Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global AI Pathology Analysis System market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI Pathology Analysis System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI Pathology Analysis System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI Pathology Analysis System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI Pathology Analysis System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI Pathology Analysis System include Visiopharm, PathAI, Aiforia, Indica Labs, aetherAI, Proscia, Mindpeak, Techcyte and Qritive, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI Pathology Analysis System, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI Pathology Analysis System, also provides the revenue of main regions and countries. Of the upcoming market potential for AI Pathology Analysis System, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI Pathology Analysis System revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI Pathology Analysis System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI Pathology Analysis System revenue, projected growth trends, production technology, application and end-user industry.

AI Pathology Analysis System Segment by Company

Visiopharm

PathAI

Aiforia

Indica Labs

aetherAI

Proscia

Mindpeak

Techcyte

Qritive

Deepathology

Franklin.ai

Roche Diagnostics

Flagship

Dedalus Group

Ibex Medical Analytics

AI Pathology Analysis System Segment by Type

On-premises

Cloud-based

AI Pathology Analysis System Segment by Application

Hospital

Clinic

Others

AI Pathology Analysis System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Pathology Analysis System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Pathology Analysis System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Pathology Analysis System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI Pathology Analysis System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI Pathology Analysis System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI Pathology Analysis System revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI Pathology Analysis System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. On-premises Major Player Table 3. Cloud-based Major Player Table 4. Global AI Pathology Analysis System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Others Major Player Table 8. AI Pathology Analysis System Industry Trends Table 9. AI Pathology Analysis System Industry Drivers Table 10. AI Pathology Analysis System Industry Opportunities and Challenges Table 11. AI Pathology Analysis System Industry Restraints Table 12. Global AI Pathology Analysis System Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global AI Pathology Analysis System Market Size by Region (2021-2026) & (US$ Million) Table 14. Global AI Pathology Analysis System Market Share by Region (2021-2026) Table 15. Global AI Pathology Analysis System Market Size by Region (2027-2032) & (US$ Million) Table 16. Global AI Pathology Analysis System Market Share by Region (2027-2032) Table 17. Global AI Pathology Analysis System Revenue by Players (US$ Million) & (2021-2026) Table 18. Global AI Pathology Analysis System Revenue Market Share by Players (2021-2026) Table 19. Global AI Pathology Analysis System Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global AI Pathology Analysis System Key Players Headquarters & Area Served Table 21. Global AI Pathology Analysis System Players, Product Type & Application Table 22. Global AI Pathology Analysis System Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global AI Pathology Analysis System by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global AI Pathology Analysis System Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global AI Pathology Analysis System Revenue by Type (2021-2026) & (US$ Million) Table 27. Global AI Pathology Analysis System Revenue by Type (2027-2032) & (US$ Million) Table 28. Global AI Pathology Analysis System Revenue Market Share by Type (2021-2026) Table 29. Global AI Pathology Analysis System Revenue Market Share by Type (2027-2032) Table 30. Global AI Pathology Analysis System Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI Pathology Analysis System Revenue by Application (2021-2026) & (US$ Million) Table 32. Global AI Pathology Analysis System Revenue by Application (2027-2032) & (US$ Million) Table 33. Global AI Pathology Analysis System Revenue Market Share by Application (2021-2026) Table 34. Global AI Pathology Analysis System Revenue Market Share by Application (2027-2032) Table 35. Visiopharm Company Information Table 36. Visiopharm Business Overview Table 37. Visiopharm AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Visiopharm AI Pathology Analysis System Product Portfolio Table 39. Visiopharm Recent Development Table 40. PathAI Company Information Table 41. PathAI Business Overview Table 42. PathAI AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. PathAI AI Pathology Analysis System Product Portfolio Table 44. PathAI Recent Development Table 45. Aiforia Company Information Table 46. Aiforia Business Overview Table 47. Aiforia AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Aiforia AI Pathology Analysis System Product Portfolio Table 49. Aiforia Recent Development Table 50. Indica Labs Company Information Table 51. Indica Labs Business Overview Table 52. Indica Labs AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Indica Labs AI Pathology Analysis System Product Portfolio Table 54. Indica Labs Recent Development Table 55. aetherAI Company Information Table 56. aetherAI Business Overview Table 57. aetherAI AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. aetherAI AI Pathology Analysis System Product Portfolio Table 59. aetherAI Recent Development Table 60. Proscia Company Information Table 61. Proscia Business Overview Table 62. Proscia AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Proscia AI Pathology Analysis System Product Portfolio Table 64. Proscia Recent Development Table 65. Mindpeak Company Information Table 66. Mindpeak Business Overview Table 67. Mindpeak AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Mindpeak AI Pathology Analysis System Product Portfolio Table 69. Mindpeak Recent Development Table 70. Techcyte Company Information Table 71. Techcyte Business Overview Table 72. Techcyte AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Techcyte AI Pathology Analysis System Product Portfolio Table 74. Techcyte Recent Development Table 75. Qritive Company Information Table 76. Qritive Business Overview Table 77. Qritive AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Qritive AI Pathology Analysis System Product Portfolio Table 79. Qritive Recent Development Table 80. Deepathology Company Information Table 81. Deepathology Business Overview Table 82. Deepathology AI Pathology Analysis System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Deepathology AI Pathology Analysis System Product Portfolio Table 84. Deepathology Recent Development Table 85. Franklin.ai Company Information Table 86. Franklin.ai Business Overview Table 87. Franklin.ai AI Pathology Analysis System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Franklin.ai AI Pathology Analysis System Product Portfolio Table 89. Franklin.ai Recent Development Table 90. Roche Diagnostics Company Information Table 91. Roche Diagnostics Business Overview Table 92. Roche Diagnostics AI Pathology Analysis System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Roche Diagnostics AI Pathology Analysis System Product Portfolio Table 94. Roche Diagnostics Recent Development Table 95. Flagship Company Information Table 96. Flagship Business Overview Table 97. Flagship AI Pathology Analysis System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Flagship AI Pathology Analysis System Product Portfolio Table 99. Flagship Recent Development Table 100. Dedalus Group Company Information Table 101. Dedalus Group Business Overview Table 102. Dedalus Group AI Pathology Analysis System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Dedalus Group AI Pathology Analysis System Product Portfolio Table 104. Dedalus Group Recent Development Table 105. Ibex Medical Analytics Company Information Table 106. Ibex Medical Analytics Business Overview Table 107. Ibex Medical Analytics AI Pathology Analysis System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Ibex Medical Analytics AI Pathology Analysis System Product Portfolio Table 109. Ibex Medical Analytics Recent Development Table 110. North America AI Pathology Analysis System Revenue by Type (2021-2026) & (US$ Million) Table 111. North America AI Pathology Analysis System Revenue by Type (2027-2032) & (US$ Million) Table 112. North America AI Pathology Analysis System Revenue by Application (2021-2026) & (US$ Million) Table 113. North America AI Pathology Analysis System Revenue by Application (2027-2032) & (US$ Million) Table 114. North America AI Pathology Analysis System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America AI Pathology Analysis System Revenue by Country (2021-2026) & (US$ Million) Table 116. North America AI Pathology Analysis System Revenue by Country (US$ Million) & (2027-2032) Table 117. Europe AI Pathology Analysis System Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe AI Pathology Analysis System Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe AI Pathology Analysis System Revenue by Application (2021-2026) & (US$ Million) Table 120. Europe AI Pathology Analysis System Revenue by Application (2027-2032) & (US$ Million) Table 121. Europe AI Pathology Analysis System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe AI Pathology Analysis System Revenue by Country (2021-2026) & (US$ Million) Table 123. Europe AI Pathology Analysis System Revenue by Country (US$ Million) & (2027-2032) Table 124. China AI Pathology Analysis System Revenue by Type (2021-2026) & (US$ Million) Table 125. China AI Pathology Analysis System Revenue by Type (2027-2032) & (US$ Million) Table 126. China AI Pathology Analysis System Revenue by Application (2021-2026) & (US$ Million) Table 127. China AI Pathology Analysis System Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia AI Pathology Analysis System Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia AI Pathology Analysis System Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia AI Pathology Analysis System Revenue by Application (2021-2026) & (US$ Million) Table 131. Asia AI Pathology Analysis System Revenue by Application (2027-2032) & (US$ Million) Table 132. Asia AI Pathology Analysis System Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia AI Pathology Analysis System Revenue by Region (US$ Million) & (2021-2026) Table 134. Asia AI Pathology Analysis System Revenue by Region (US$ Million) & (2027-2032) Table 135. SAMEA AI Pathology Analysis System Revenue by Type (2021-2026) & (US$ Million) Table 136. SAMEA AI Pathology Analysis System Revenue by Type (2027-2032) & (US$ Million) Table 137. SAMEA AI Pathology Analysis System Revenue by Application (2021-2026) & (US$ Million) Table 138. SAMEA AI Pathology Analysis System Revenue by Application (2027-2032) & (US$ Million) Table 139. SAMEA AI Pathology Analysis System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. SAMEA AI Pathology Analysis System Revenue by Country (2021-2026) & (US$ Million) Table 141. SAMEA AI Pathology Analysis System Revenue by Country (US$ Million) & (2027-2032) Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. AI Pathology Analysis System Image Figure 2. Global AI Pathology Analysis System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Pathology Analysis System Market Size Share 2021 VS 2025 VS 2032 Figure 4. On-premises Image Figure 5. Cloud-based Image Figure 6. Global AI Pathology Analysis System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global AI Pathology Analysis System Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global AI Pathology Analysis System Market Size (US$ Million) & (2021-2032) Figure 12. Global AI Pathology Analysis System Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global AI Pathology Analysis System Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global AI Pathology Analysis System Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global AI Pathology Analysis System Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global AI Pathology Analysis System Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global AI Pathology Analysis System Revenue Market Share by Type (2021-2032) Figure 19. Global AI Pathology Analysis System Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global AI Pathology Analysis System Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global AI Pathology Analysis System Revenue Market Share by Application (2021-2032) Figure 22. North America AI Pathology Analysis System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America AI Pathology Analysis System Revenue Share by Type (2021-2032) Figure 24. North America AI Pathology Analysis System Revenue Share by Application (2021-2032) Figure 25. North America AI Pathology Analysis System Revenue Share by Country (2021-2032) Figure 26. United States AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe AI Pathology Analysis System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe AI Pathology Analysis System Revenue Share by Type (2021-2032) Figure 31. Europe AI Pathology Analysis System Revenue Share by Application (2021-2032) Figure 32. Europe AI Pathology Analysis System Revenue Share by Country (2021-2032) Figure 33. Germany AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China AI Pathology Analysis System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China AI Pathology Analysis System Revenue Share by Type (2021-2032) Figure 43. China AI Pathology Analysis System Revenue Share by Application (2021-2032) Figure 44. Asia AI Pathology Analysis System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia AI Pathology Analysis System Revenue Share by Type (2021-2032) Figure 46. Asia AI Pathology Analysis System Revenue Share by Application (2021-2032) Figure 47. Asia AI Pathology Analysis System Revenue Share by Region (2021-2032) Figure 48. Japan AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA AI Pathology Analysis System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA AI Pathology Analysis System Revenue Share by Type (2021-2032) Figure 56. SAMEA AI Pathology Analysis System Revenue Share by Application (2021-2032) Figure 57. SAMEA AI Pathology Analysis System Revenue Share by Country (2021-2032) Figure 58. Brazil AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt AI Pathology Analysis System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • On-premises
  • Cloud-based
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Visiopharm
  • PathAI
  • Aiforia
  • Indica Labs
  • aetherAI
  • Proscia
  • Mindpeak
  • Techcyte
  • Qritive
  • Deepathology
  • Franklin.ai
  • Roche Diagnostics
  • Flagship
  • Dedalus Group
  • Ibex Medical Analytics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI Pathology Analysis System Market by Type
  3. 1.2.1 Global AI Pathology Analysis System Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 On-premises
  5. 1.2.3 Cloud-based
  6. 1.3 AI Pathology Analysis System Market by Application
  7. 1.3.1 Global AI Pathology Analysis System Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 AI Pathology Analysis System Market Dynamics
  1. 2.1 AI Pathology Analysis System Industry Trends
  2. 2.2 AI Pathology Analysis System Industry Drivers
  3. 2.3 AI Pathology Analysis System Industry Opportunities and Challenges
  4. 2.4 AI Pathology Analysis System Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI Pathology Analysis System Market Perspective (2021-2032)
  2. 3.2 Global AI Pathology Analysis System Growth Trends by Region
  3. 3.2.1 Global AI Pathology Analysis System Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI Pathology Analysis System Market Size by Region (2021-2026)
  5. 3.2.3 Global AI Pathology Analysis System Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI Pathology Analysis System Revenue by Players
  2. 4.1.1 Global AI Pathology Analysis System Revenue by Players (2021-2026)
  3. 4.1.2 Global AI Pathology Analysis System Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI Pathology Analysis System Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI Pathology Analysis System Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI Pathology Analysis System Key Players Headquarters & Area Served
  7. 4.4 Global AI Pathology Analysis System Players, Product Type & Application
  8. 4.5 Global AI Pathology Analysis System Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI Pathology Analysis System Market CR5 and HHI
  11. 4.6.3 2025 AI Pathology Analysis System Tier 1, Tier 2, and Tier 3
5 AI Pathology Analysis System Market Size by Type
  1. 5.1 Global AI Pathology Analysis System Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI Pathology Analysis System Revenue by Type (2021-2032)
  3. 5.3 Global AI Pathology Analysis System Revenue Market Share by Type (2021-2032)
6 AI Pathology Analysis System Market Size by Application
  1. 6.1 Global AI Pathology Analysis System Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI Pathology Analysis System Revenue by Application (2021-2032)
  3. 6.3 Global AI Pathology Analysis System Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Visiopharm
  2. 7.1.1 Visiopharm Company Information
  3. 7.1.2 Visiopharm Business Overview
  4. 7.1.3 Visiopharm AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Visiopharm AI Pathology Analysis System Product Portfolio
  6. 7.1.5 Visiopharm Recent Developments
  7. 7.2 PathAI
  8. 7.2.1 PathAI Company Information
  9. 7.2.2 PathAI Business Overview
  10. 7.2.3 PathAI AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  11. 7.2.4 PathAI AI Pathology Analysis System Product Portfolio
  12. 7.2.5 PathAI Recent Developments
  13. 7.3 Aiforia
  14. 7.3.1 Aiforia Company Information
  15. 7.3.2 Aiforia Business Overview
  16. 7.3.3 Aiforia AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Aiforia AI Pathology Analysis System Product Portfolio
  18. 7.3.5 Aiforia Recent Developments
  19. 7.4 Indica Labs
  20. 7.4.1 Indica Labs Company Information
  21. 7.4.2 Indica Labs Business Overview
  22. 7.4.3 Indica Labs AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Indica Labs AI Pathology Analysis System Product Portfolio
  24. 7.4.5 Indica Labs Recent Developments
  25. 7.5 aetherAI
  26. 7.5.1 aetherAI Company Information
  27. 7.5.2 aetherAI Business Overview
  28. 7.5.3 aetherAI AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  29. 7.5.4 aetherAI AI Pathology Analysis System Product Portfolio
  30. 7.5.5 aetherAI Recent Developments
  31. 7.6 Proscia
  32. 7.6.1 Proscia Company Information
  33. 7.6.2 Proscia Business Overview
  34. 7.6.3 Proscia AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Proscia AI Pathology Analysis System Product Portfolio
  36. 7.6.5 Proscia Recent Developments
  37. 7.7 Mindpeak
  38. 7.7.1 Mindpeak Company Information
  39. 7.7.2 Mindpeak Business Overview
  40. 7.7.3 Mindpeak AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Mindpeak AI Pathology Analysis System Product Portfolio
  42. 7.7.5 Mindpeak Recent Developments
  43. 7.8 Techcyte
  44. 7.8.1 Techcyte Company Information
  45. 7.8.2 Techcyte Business Overview
  46. 7.8.3 Techcyte AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Techcyte AI Pathology Analysis System Product Portfolio
  48. 7.8.5 Techcyte Recent Developments
  49. 7.9 Qritive
  50. 7.9.1 Qritive Company Information
  51. 7.9.2 Qritive Business Overview
  52. 7.9.3 Qritive AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Qritive AI Pathology Analysis System Product Portfolio
  54. 7.9.5 Qritive Recent Developments
  55. 7.10 Deepathology
  56. 7.10.1 Deepathology Company Information
  57. 7.10.2 Deepathology Business Overview
  58. 7.10.3 Deepathology AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Deepathology AI Pathology Analysis System Product Portfolio
  60. 7.10.5 Deepathology Recent Developments
  61. 7.11 Franklin.ai
  62. 7.11.1 Franklin.ai Company Information
  63. 7.11.2 Franklin.ai Business Overview
  64. 7.11.3 Franklin.ai AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Franklin.ai AI Pathology Analysis System Product Portfolio
  66. 7.11.5 Franklin.ai Recent Developments
  67. 7.12 Roche Diagnostics
  68. 7.12.1 Roche Diagnostics Company Information
  69. 7.12.2 Roche Diagnostics Business Overview
  70. 7.12.3 Roche Diagnostics AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Roche Diagnostics AI Pathology Analysis System Product Portfolio
  72. 7.12.5 Roche Diagnostics Recent Developments
  73. 7.13 Flagship
  74. 7.13.1 Flagship Company Information
  75. 7.13.2 Flagship Business Overview
  76. 7.13.3 Flagship AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Flagship AI Pathology Analysis System Product Portfolio
  78. 7.13.5 Flagship Recent Developments
  79. 7.14 Dedalus Group
  80. 7.14.1 Dedalus Group Company Information
  81. 7.14.2 Dedalus Group Business Overview
  82. 7.14.3 Dedalus Group AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Dedalus Group AI Pathology Analysis System Product Portfolio
  84. 7.14.5 Dedalus Group Recent Developments
  85. 7.15 Ibex Medical Analytics
  86. 7.15.1 Ibex Medical Analytics Company Information
  87. 7.15.2 Ibex Medical Analytics Business Overview
  88. 7.15.3 Ibex Medical Analytics AI Pathology Analysis System Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Ibex Medical Analytics AI Pathology Analysis System Product Portfolio
  90. 7.15.5 Ibex Medical Analytics Recent Developments
8 North America
  1. 8.1 North America AI Pathology Analysis System Revenue (2021-2032)
  2. 8.2 North America AI Pathology Analysis System Revenue by Type (2021-2032)
  3. 8.2.1 North America AI Pathology Analysis System Revenue by Type (2021-2026)
  4. 8.2.2 North America AI Pathology Analysis System Revenue by Type (2027-2032)
  5. 8.3 North America AI Pathology Analysis System Revenue Share by Type (2021-2032)
  6. 8.4 North America AI Pathology Analysis System Revenue by Application (2021-2032)
  7. 8.4.1 North America AI Pathology Analysis System Revenue by Application (2021-2026)
  8. 8.4.2 North America AI Pathology Analysis System Revenue by Application (2027-2032)
  9. 8.5 North America AI Pathology Analysis System Revenue Share by Application (2021-2032)
  10. 8.6 North America AI Pathology Analysis System Revenue by Country
  11. 8.6.1 North America AI Pathology Analysis System Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI Pathology Analysis System Revenue by Country (2021-2026)
  13. 8.6.3 North America AI Pathology Analysis System Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI Pathology Analysis System Revenue (2021-2032)
  2. 9.2 Europe AI Pathology Analysis System Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI Pathology Analysis System Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI Pathology Analysis System Revenue by Type (2027-2032)
  5. 9.3 Europe AI Pathology Analysis System Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI Pathology Analysis System Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI Pathology Analysis System Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI Pathology Analysis System Revenue by Application (2027-2032)
  9. 9.5 Europe AI Pathology Analysis System Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI Pathology Analysis System Revenue by Country
  11. 9.6.1 Europe AI Pathology Analysis System Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI Pathology Analysis System Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI Pathology Analysis System Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI Pathology Analysis System Revenue (2021-2032)
  2. 10.2 China AI Pathology Analysis System Revenue by Type (2021-2032)
  3. 10.2.1 China AI Pathology Analysis System Revenue by Type (2021-2026)
  4. 10.2.2 China AI Pathology Analysis System Revenue by Type (2027-2032)
  5. 10.3 China AI Pathology Analysis System Revenue Share by Type (2021-2032)
  6. 10.4 China AI Pathology Analysis System Revenue by Application (2021-2032)
  7. 10.4.1 China AI Pathology Analysis System Revenue by Application (2021-2026)
  8. 10.4.2 China AI Pathology Analysis System Revenue by Application (2027-2032)
  9. 10.5 China AI Pathology Analysis System Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI Pathology Analysis System Revenue (2021-2032)
  2. 11.2 Asia AI Pathology Analysis System Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI Pathology Analysis System Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI Pathology Analysis System Revenue by Type (2027-2032)
  5. 11.3 Asia AI Pathology Analysis System Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI Pathology Analysis System Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI Pathology Analysis System Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI Pathology Analysis System Revenue by Application (2027-2032)
  9. 11.5 Asia AI Pathology Analysis System Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI Pathology Analysis System Revenue by Country
  11. 11.6.1 Asia AI Pathology Analysis System Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI Pathology Analysis System Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI Pathology Analysis System Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI Pathology Analysis System Revenue (2021-2032)
  2. 12.2 SAMEA AI Pathology Analysis System Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI Pathology Analysis System Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI Pathology Analysis System Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI Pathology Analysis System Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI Pathology Analysis System Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI Pathology Analysis System Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI Pathology Analysis System Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI Pathology Analysis System Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI Pathology Analysis System Revenue by Country
  11. 12.6.1 SAMEA AI Pathology Analysis System Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI Pathology Analysis System Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI Pathology Analysis System Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst